methylprednisolone acetate has been researched along with Brain Disorders in 1 studies
Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, S | 1 |
| Hirashima, Y | 1 |
| Takaba, M | 1 |
| Takaku, A | 1 |
1 other study available for methylprednisolone acetate and Brain Disorders
| Article | Year |
|---|---|
Administration of methylprednisolone acetate into the subdural cavity in an infant with subdural fluid collection. PAF is a good indicator of the efficacy of the treatment.
Topics: Anti-Inflammatory Agents; Biomarkers; Brain Diseases; Cardiac Surgical Procedures; Drainage; Female; | 1998 |